Characterization of autoantibodies to vasoactive intestinal peptide in asthma

[1]  S. Paul.  Decreased selectivity of vasoactive intestinal peptide receptors by GTP. , 1989, Biochemical pharmacology.

[2]  S. Said,et al.  Regulatory Aspects of the Vasoactive Intestinal Peptide Receptor in Lung a , 1988, Annals of the New York Academy of Sciences.

[3]  S. I. Said.  Influence of neuropeptides on airway smooth muscle. , 1987, The American review of respiratory disease.

[4]  E. Kubota,et al.  High affinity peptide histidine isoleucine-preferring receptors in rat liver. , 1987, Life sciences.

[5]  C. Pert,et al.  CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis , 1987, FEBS letters.

[6]  S. Said,et al.  Characterization of receptors for vasoactive intestinal peptide solubilized from the lung. , 1987, The Journal of biological chemistry.

[7]  M. Thorndyke,et al.  Purification and characterisation of VIP from two species of dogfish , 1986, Peptides.

[8]  G. Rosselin.  The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity , 1986, Peptides.

[9]  P. Barnes,et al.  Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. , 1986, The Journal of pharmacology and experimental therapeutics.

[10]  T. Jenssen,et al.  Plasma gastrointestinal regulatory peptides in exercise-induced asthma. , 1986, European journal of respiratory diseases.

[11]  G A McPherson,et al.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. , 1985, Journal of pharmacological methods.

[12]  S. Said,et al.  Autoantibody to vasoactive intestinal peptide in human circulation. , 1985, Biochemical and biophysical research communications.

[13]  S. Said,et al.  Purification of [125I]-vasoactive intestinal peptide by reverse-phase HPLC , 1984, Peptides.

[14]  S. Said.  Vasoactive intestinal polypeptide (VIP): Current status , 1984, Peptides.

[15]  H. Okamoto,et al.  Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27 , 1983, Nature.

[16]  Y. Matsuzaki,et al.  Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways. , 1980, Science.

[17]  R. Yalow,et al.  Degradation of vasoactive intestinal polypeptide by tissue homogenates. , 1980, Biochemical and biophysical research communications.

[18]  T. Adrian,et al.  AUTOIMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN , 1979, The Lancet.

[19]  A. Nilsson.  Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence , 1975, FEBS letters.

[20]  A. Szentivanyi.  The beta adrenergic theory of the atopic abnormality in bronchial asthma , 1968 .

[21]  S. Said,et al.  Human autoantibody to vasoactive intestinal peptide: increased incidence in muscular exercise. , 1988, Life sciences.

[22]  R. Crystal,et al.  Does de novo immunoglobulin synthesis occur on the epithelial surface of the human lower respiratory tract? , 1988, The American review of respiratory disease.

[23]  R. Hy.  Identification and rôle of immunoglobulins in respiratory secretions. , 1987 .

[24]  L. Woie,et al.  Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in humans. , 1986, General pharmacology.

[25]  P. Barnes,et al.  Autonomic regulation of the airways. , 1984, Annual review of medicine.

[26]  N. Khansari,et al.  Immune elimination of aging platelets by autologous monocytes: role of membrane‐specific autoantibody , 1983, European journal of immunology.

[27]  M. Bryant.  Vasoactive intestinal peptide (VIP). , 1978, Journal of clinical pathology. Supplement.